234 related articles for article (PubMed ID: 20946923)
21. Development and evaluation of optimized sucrose ester stabilized oleanolic acid nanosuspensions prepared by wet ball milling with design of experiments.
Li W; Ng KY; Heng PW
Biol Pharm Bull; 2014; 37(6):926-37. PubMed ID: 24882406
[TBL] [Abstract][Full Text] [Related]
22. Generation of wear during the production of drug nanosuspensions by wet media milling.
Juhnke M; Märtin D; John E
Eur J Pharm Biopharm; 2012 May; 81(1):214-22. PubMed ID: 22269938
[TBL] [Abstract][Full Text] [Related]
23. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application.
Agnihotri SM; Vavia PR
Nanomedicine; 2009 Mar; 5(1):90-5. PubMed ID: 18823824
[TBL] [Abstract][Full Text] [Related]
24. Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.
Niu X; Zou W; Liu C; Zhang N; Fu C
Drug Dev Ind Pharm; 2009 Nov; 35(11):1375-83. PubMed ID: 19832638
[TBL] [Abstract][Full Text] [Related]
25. Nanosuspension for parenteral delivery of a p-terphenyl derivative: preparation, characteristics and pharmacokinetic studies.
Tian X; Li H; Zhang D; Liu G; Jia L; Zheng D; Shen J; Shen Y; Zhang Q
Colloids Surf B Biointerfaces; 2013 Aug; 108():29-33. PubMed ID: 23528604
[TBL] [Abstract][Full Text] [Related]
26. Development and comparison of intramuscularly long-acting paliperidone palmitate nanosuspensions with different particle size.
Leng D; Chen H; Li G; Guo M; Zhu Z; Xu L; Wang Y
Int J Pharm; 2014 Sep; 472(1-2):380-5. PubMed ID: 24882037
[TBL] [Abstract][Full Text] [Related]
27. Investigation of preparation parameters of nanosuspension by top-down media milling to improve the dissolution of poorly water-soluble glyburide.
Singh SK; Srinivasan KK; Gowthamarajan K; Singare DS; Prakash D; Gaikwad NB
Eur J Pharm Biopharm; 2011 Aug; 78(3):441-6. PubMed ID: 21439378
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
Du B; Li XT; Zhao Y; A YM; Zhang ZZ
Pharmazie; 2010 Jul; 65(7):471-6. PubMed ID: 20662313
[TBL] [Abstract][Full Text] [Related]
29. Formulation, characterization and testing of tetracaine hydrochloride-loaded albumin-chitosan microparticles for ocular drug delivery.
Addo RT; Siddig A; Siwale R; Patel NJ; Akande J; Uddin AN; D'Souza MJ
J Microencapsul; 2010; 27(2):95-104. PubMed ID: 20055748
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
Wang Y; Zhang D; Liu Z; Liu G; Duan C; Jia L; Feng F; Zhang X; Shi Y; Zhang Q
Nanotechnology; 2010 Apr; 21(15):155104. PubMed ID: 20332565
[TBL] [Abstract][Full Text] [Related]
31. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
[TBL] [Abstract][Full Text] [Related]
32. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
33. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
Kayaert P; Li B; Jimidar I; Rombaut P; Ahssini F; Van den Mooter G
Eur J Pharm Biopharm; 2010 Nov; 76(3):507-13. PubMed ID: 20887787
[TBL] [Abstract][Full Text] [Related]
34. Food proteins as novel nanosuspension stabilizers for poorly water-soluble drugs.
He W; Lu Y; Qi J; Chen L; Hu F; Wu W
Int J Pharm; 2013 Jan; 441(1-2):269-78. PubMed ID: 23194889
[TBL] [Abstract][Full Text] [Related]
35. New method for the effective production of ultrafine drug nanocrystals.
Möschwitzer J; Müller RH
J Nanosci Nanotechnol; 2006; 6(9-10):3145-53. PubMed ID: 17048530
[TBL] [Abstract][Full Text] [Related]
36. Cyclosporine A Nanosuspensions for Ophthalmic Delivery: A Comparative Study between Cationic Nanoparticles and Drug-Core Mucus Penetrating Nanoparticles.
Yan R; Xu L; Wang Q; Wu Z; Zhang H; Gan L
Mol Pharm; 2021 Dec; 18(12):4290-4298. PubMed ID: 34731571
[TBL] [Abstract][Full Text] [Related]
37. Production and characterization of Hesperetin nanosuspensions for dermal delivery.
Mishra PR; Al Shaal L; Müller RH; Keck CM
Int J Pharm; 2009 Apr; 371(1-2):182-9. PubMed ID: 19162147
[TBL] [Abstract][Full Text] [Related]
38. An Intensified Vibratory Milling Process for Enhancing the Breakage Kinetics during the Preparation of Drug Nanosuspensions.
Li M; Zhang L; Davé RN; Bilgili E
AAPS PharmSciTech; 2016 Apr; 17(2):389-99. PubMed ID: 26182907
[TBL] [Abstract][Full Text] [Related]
39. Toward understanding the evolution of griseofulvin crystal structure to a mesophase after cryogenic milling.
Feng T; Bates S; Carvajal MT
Int J Pharm; 2009 Feb; 367(1-2):16-9. PubMed ID: 19013224
[TBL] [Abstract][Full Text] [Related]
40. Nanosuspensions: a promising drug delivery strategy.
Patravale VB; Date AA; Kulkarni RM
J Pharm Pharmacol; 2004 Jul; 56(7):827-40. PubMed ID: 15233860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
